Literature DB >> 26338986

Applying the resources and supports in self-management framework to examine ophthalmologist-patient communication and glaucoma medication adherence.

B Sleath1, D M Carpenter2, S J Blalock2, R Sayner2, K W Muir3, C Slota2, A L Giangiacomo4, M E Hartnett5, G Tudor6, A L Robin7.   

Abstract

Little is known about how ophthalmologist-patient communication over time is associated with glaucoma patient long-term adherence. The purpose of our study was to examine the association between provider use of components of the resources and supports in self-management model when communicating with patients and adherence to glaucoma medications measured electronically over an 8-month period. In this longitudinal prospective cohort study, the main variables studied were ophthalmologist communication-individualized assessment, collaborative goal setting and skills enhancement. Patients with glaucoma who were newly prescribed or on glaucoma medications were recruited from six ophthalmology clinics. Patients' baseline and next follow-up visits were videotape-recorded. Patients were interviewed after their visits. Patients used medication event monitoring systems (MEMS) for 8 months after enrollment into the study, and adherence was measured electronically using MEMS for 240 days after their visits. Two hundred and seventy-nine patients participated. Patient race and regimen complexity were negatively associated with glaucoma medication adherence over an 8-month period. Provider communication behaviors, including providing education and positive reinforcement, can improve patient adherence to glaucoma medications over an 8-month period.
© The Author 2015. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 26338986      PMCID: PMC4668753          DOI: 10.1093/her/cyv034

Source DB:  PubMed          Journal:  Health Educ Res        ISSN: 0268-1153


  31 in total

1.  Health literacy and adherence to glaucoma therapy.

Authors:  Kelly W Muir; Cecile Santiago-Turla; Sandra S Stinnett; Leon W Herndon; R Rand Allingham; Pratap Challa; Paul P Lee
Journal:  Am J Ophthalmol       Date:  2006-08       Impact factor: 5.258

2.  Validation of a short version of the glaucoma medication self-efficacy questionnaire.

Authors:  Betsy Sleath; Susan J Blalock; Jennifer L Stone; Asheley Cockrell Skinner; David Covert; Kelly Muir; Alan L Robin
Journal:  Br J Ophthalmol       Date:  2011-05-24       Impact factor: 4.638

3.  Compliance with topical timolol treatment.

Authors:  M A Kass; M Gordon; R E Morley; D W Meltzer; J J Goldberg
Journal:  Am J Ophthalmol       Date:  1987-02-15       Impact factor: 5.258

4.  Survey on vision-related quality of life and self-management among patients with glaucoma.

Authors:  Peixia Wu; Shuxin Xi; Haiou Xia; Huijuan Lu; Wenyi Guo
Journal:  J Glaucoma       Date:  2014-02       Impact factor: 2.503

5.  The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.

Authors:  Betsy Sleath; Susan Blalock; David Covert; Jennifer L Stone; Asheley Cockrell Skinner; Kelly Muir; Alan L Robin
Journal:  Ophthalmology       Date:  2011-12       Impact factor: 12.079

6.  Patient-reported behavior and problems in using glaucoma medications.

Authors:  Betsy Sleath; Alan L Robin; David Covert; John E Byrd; Gail Tudor; Bonnie Svarstad
Journal:  Ophthalmology       Date:  2006-02-03       Impact factor: 12.079

7.  Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence.

Authors:  Betsy Sleath; Susan J Blalock; Delesha M Carpenter; Robyn Sayner; Kelly W Muir; Catherine Slota; Scott D Lawrence; Annette L Giangiacomo; Mary Elizabeth Hartnett; Gail Tudor; Jason A Goldsmith; Alan L Robin
Journal:  Ophthalmology       Date:  2014-12-24       Impact factor: 12.079

Review 8.  Risk communication and shared decision making in the care of patients with osteoporosis.

Authors:  E Michael Lewiecki
Journal:  J Clin Densitom       Date:  2010-07-21       Impact factor: 2.617

9.  Compliance in patients prescribed eyedrops for glaucoma.

Authors:  S C Patel; G L Spaeth
Journal:  Ophthalmic Surg       Date:  1995 May-Jun

10.  Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.

Authors:  Joseph Caprioli; Anne L Coleman
Journal:  Ophthalmology       Date:  2008-02-20       Impact factor: 12.079

View more
  6 in total

1.  Glaucoma patient-provider communication about vision quality-of-life.

Authors:  Betsy Sleath; Robyn Sayner; Michelle Vitko; Delesha M Carpenter; Susan J Blalock; Kelly W Muir; Annette L Giangiacomo; Mary Elizabeth Hartnett; Alan L Robin
Journal:  Patient Educ Couns       Date:  2016-11-22

2.  African American Patient Preferences for Glaucoma Education.

Authors:  Betsy Sleath; Scott Davis; Robyn Sayner; Delesha M Carpenter; Terence Johnson; Susan J Blalock; Alan L Robin
Journal:  Optom Vis Sci       Date:  2017-04       Impact factor: 1.973

Review 3.  Medical Management of Glaucoma in the 21st Century from a Canadian Perspective.

Authors:  Paul Harasymowycz; Catherine Birt; Patrick Gooi; Lisa Heckler; Cindy Hutnik; Delan Jinapriya; Lesya Shuba; David Yan; Radmila Day
Journal:  J Ophthalmol       Date:  2016-11-08       Impact factor: 1.909

4.  Evaluating Eye Drop Instillation Technique and Its Determinants in Glaucoma Patients.

Authors:  Xinbo Gao; Qiongman Yang; Wenmin Huang; Tingting Chen; Chengguo Zuo; Xinyan Li; Wuyou Gao; Huiming Xiao
Journal:  J Ophthalmol       Date:  2018-04-08       Impact factor: 1.909

5.  Subjective and objective assessment of the eye drop instillation technique: A hospital-based cross-sectional study.

Authors:  Ugam Usgaonkar; Viraj Zambaulicar; Aksha Shetty
Journal:  Indian J Ophthalmol       Date:  2021-10       Impact factor: 1.848

6.  Increasing Engagement of African American Patients with Glaucoma during Medical Encounters: Creation of a Pre-visit Video.

Authors:  Betsy Sleath; Scott A Davis; Delesha M Carpenter; Alan L Robin; Kelly W Muir; Charles Lee; Nacire Garcia; Donald L Budenz
Journal:  Optom Vis Sci       Date:  2020-07       Impact factor: 2.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.